Evaluation of efficacy of dietary program for hypertensive patients

Evaluation of efficacy of dietary program for hypertensive patients - Evaluation of efficacy of dietary program for hypertensive patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000050329

Enrollment

Registered

2023-02-20

Start date

2023-01-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

Notification of measurement result of urinary sodium/potassium ratio Notification of measurement result of urinary sodium/potassium ratio and providing dietary program through the smartphone APP.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hypertensive patients over 20 years of age receiving any care (e.g., medication) for hypertension at "TELEMEDEASE" services using smartphone. The definition of hypertensive patients is those who use TELEMEDEASE hypertension telemedicine support application and are taking measures to control their hypertension, regardless of their blood pressure levels or whether or not they are taking medication.

Exclusion criteria

Exclusion criteria: Those who have kidney disease or abnormal renal function and are restricted in salt and potassium intake. Those who participate other clinical studies. Those who are considered inappropriate by principal investigator.

Design outcomes

Primary

Measure	Time frame
Molar ratio of urinary sodium/potassium concentration	—

Secondary

Measure	Time frame
Home blood pressure	—

Countries

Japan

Contacts

Public ContactYusuke Ushida

KAGOME CO., LTD. Innovation Division

Yusuke_Ushida@kagome.co.jp0287362935

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026